Related Experiment Video
Updated: May 30, 2026

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis
Published on: May 10, 2022
'Get with the Program!': pharmaceutical marketing, symptom checklists and self-diagnosis
1Drexel University, Culture & Communication, 3141 Chestnut Street, Philadelphia, USA. mfe@drexel.edu
Pharmaceutical companies use direct-to-consumer advertising to promote self-diagnosis for conditions like Premenstrual Dysphoric Disorder (PMDD). This marketing strategy transforms patients into consumers, driving demand for specific drugs.
Area of Science:
- Sociology of Medicine
- Pharmaceutical Marketing
- Health Communication
Background:
- Direct-to-consumer advertising (DTC) of pharmaceuticals has influenced disease diagnosis and prescribing patterns in the US.
- Pharmaceutical companies invest heavily in marketing to establish new disease diagnoses, protecting intellectual property and increasing profits.
- While disease branding is studied, the sociological implications of self-diagnosis promotion in pharmaceutical marketing receive limited attention.
Purpose of the Study:
- To analyze branded disease awareness campaigns that utilize self-diagnostic tools sponsored by pharmaceutical companies.
- To illustrate how marketing self-diagnosis transforms patients into consumers, aligning with pharmaceutical objectives, using Premenstrual Dysphoric Disorder (PMDD) as a case study.
- To examine how self-diagnosis marketing extends beyond medical classification to become a tool for constructing consumers who demand specific diagnoses.
Main Methods:
- Review and analysis of branded disease awareness campaigns.
- Case study focusing on Premenstrual Dysphoric Disorder (PMDD) marketing.
- Contextualization within the theoretical framework of the sociology of diagnosis.
Main Results:
- Pharmaceutical marketing campaigns actively promote self-diagnostic tools to influence patient behavior and demand.
- The marketing of self-diagnosis for conditions like PMDD converts patients into consumers seeking diagnoses that align with drug company goals.
- Self-diagnosis promotion functions as a marketing strategy, shaping consumer demand for specific medical diagnoses.
Conclusions:
- Pharmaceutical companies leverage self-diagnosis marketing to drive demand for their branded drugs by creating informed consumers.
- The practice of marketing self-diagnosis redefines the role of diagnosis from a medical classification tool to a commercial strategy.
- Understanding the sociology of diagnosis is crucial for analyzing how pharmaceutical marketing influences patient perceptions and healthcare seeking behaviors.
More Related Videos
Related Concept Videos
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Dosage Regimens: Designs and Approaches
Drug Therapy
Antianxiety Medications
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Diagnostic and Statistical Manual of Mental Disorders (DSM)

